Literature DB >> 3783323

DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors.

R A Walker, R S Camplejohn.   

Abstract

The expression of transferrin and epidermal growth factor receptors in breast carcinomas, as detected by immunohistochemistry, has been compared with DNA ploidy and S-phase content of the same tumours as determined by DNA flow cytometry of fixed, paraffin embedded tissue, and with tumour differentiation. Good correlations have been found between DNA ploidy, S-phase content and differentiation. The expression of transferrin receptor appears to relate to DNA ploidy, but only to a limited extent to S-phase content, indicating that in breast carcinomas immunoreactive transferrin receptor may not be directly related to proliferation. The presence of epidermal growth factor receptor shows a close correlation with high S-phase content, but only a lesser association with DNA ploidy, and no correlation with tumour differentiation. DNA flow cytometry provides a more reliable method of assessing the relationship of such growth factor receptors in breast carcinomas to cell proliferation, than that obtained from more subjective tumour grading criteria.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3783323     DOI: 10.1002/path.1711500107

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

Review 1.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 2.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

3.  Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction.

Authors:  R Prior; G Reifenberger; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast.

Authors:  P Möller; G Mechtersheimer; M Kaufmann; G Moldenhauer; F Momburg; T Mattfeldt; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Patterns of epidermal growth factor receptor amplification in malignant gliomas.

Authors:  G Sauter; T Maeda; F M Waldman; R L Davis; B G Feuerstein
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  The prognostic significance of epidermal growth factor receptor expression in breast cancer.

Authors:  M Noguchi; Y Mizukami; K Kinoshita; M Earashi; M Thomas; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  Prognostic value of epidermal growth factor receptor in node-positive breast cancer.

Authors:  M Grimaux; S Romain; Y Remvikos; P M Martin; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

8.  Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.

Authors:  M Toi; T Tominaga; A Osaki; T Toge
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

9.  Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

Authors:  R A Walker; R S Camplejohn
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

10.  Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas.

Authors:  G Cattoretti; S Andreola; C Clemente; L D'Amato; F Rilke
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.